Novel approach to bioavailability testing: statistical method for comparing drug input calculated by a least-squares...

Area of Science:

• Pharmacokinetics
• Drug bioavailability
• Biopharmaceutics

Background:

• Traditional bioavailability testing often relies on specific pharmacokinetic models.
• These models require assumptions about absorption, distribution, and elimination rates.
• A need exists for a more flexible and intrinsic method for bioavailability evaluation.

Purpose of the Study:

• To introduce a novel, model-independent approach for bioavailability testing.
• To enable a more detailed and intrinsic comparison of drug input characteristics.
• To provide a method that does not rely on pharmacokinetic rate constants or volume terms.

Main Methods:

• The proposed method requires intravenous drug administration.
• It evaluates drug input based on assumptions similar to those for area under the curve calculations.
• No extrapolation beyond the last data point is necessary.

Main Results:

• Two key statistics are derived for comparing the rate and cumulative amount of drug input over time.
• A differential confidence profile is calculated for enhanced bioavailability comparison.
• The method demonstrated satisfactory performance on simulated data with random noise.

Conclusions:

• The novel model-independent approach offers a robust alternative for bioavailability testing.
• It provides a more intrinsic comparison of drug input characteristics than traditional methods.
• This method simplifies bioavailability assessment by avoiding complex pharmacokinetic modeling.